SLC30A3 and Bartsocas-Papas syndrome 1: GO analysis revealed possible involvement of the ‘dopamine-related pathway’, ‘zinc protein pathway’, ‘immune response’, and ‘cellular structure’ in BPs, in terms of the efficacy of UCB+EPO combination treatment, by discovering significant genes: Nr4a2 (Nurr1), Slc30a3, Sema7a, and Baiap2l1 (Table 1).